CME Group Shares Sold by Xponance Inc.

Institutional investor reduces stake in financial services provider

Mar. 3, 2026 at 7:31am

Got story updates? Submit your updates here. ›

Xponance Inc., an institutional investor, reduced its stake in CME Group Inc. (NASDAQ:CME) by 6.8% during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The fund now owns 53,317 shares of the financial services provider's stock, valued at $14.4 million.

Why it matters

CME Group operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), and the New York Mercantile Exchange (NYMEX). The company's performance is closely watched by investors and analysts as an indicator of broader financial market activity.

The details

Xponance Inc. sold 3,902 shares of CME Group stock during the third quarter, reducing its total holdings to 53,317 shares. The move comes as CME Group's stock price has fluctuated in recent months, with the share price reaching a 52-week high of $322.57 in February 2026.

  • Xponance Inc. reduced its stake in CME Group during the third quarter of 2025.

The players

Xponance Inc.

An institutional investor that reduced its stake in CME Group by 6.8% during the third quarter of 2025.

CME Group Inc.

A global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), and the New York Mercantile Exchange (NYMEX).

Got photos? Submit your photos here. ›

The takeaway

The reduction in Xponance Inc.'s stake in CME Group reflects the ongoing volatility in the financial markets and the need for institutional investors to carefully manage their portfolios. As a leading player in the derivatives market, CME Group's performance remains a key indicator of broader market trends.